Leaflet KAMRAB 150UI / ml solution for injection

Product code:
W71777001
Quantity:
1
Indicated for:
immunosuppression
Route of administration:
injectable
Substance:
human anti-rabies immunoglobulin (immunoglobulin)
ATC
J06BB05 — Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins

Precautions:

Anaphylaxis

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

Additional monitoring

This medicine is subject to additional monitoring.

Human rabies immunoglobulin is a plasma-derived product used to prevent rabies in individuals exposed to the rabies virus, usually through bites from infected animals. It provides passive immunity by supplying specific antibodies against the rabies virus.

The medication is administered via intramuscular injection, as directed by a doctor, and is used in combination with the rabies vaccine.

Side effects may include pain at the injection site, fever, allergic reactions, or, in rare cases, anaphylactic reactions.

Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about KAMRAB 150UI / ml

Substance:
human anti-rabies immunoglobulin
Date of latest medicines list:
01-06-2026
Product code:
W71777001
Concentration:
150UI / ml
Pharmaceutical form:
solution for injection
Quantity:
1
Product type:
Generic medicine
Price:
1688.59 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
KAMADA LTD. - ISRAEL
Holder:
CN UNIFARM S.A. - ROMANIA
Number:
1208/2026/01